Psyence Biomedical LTD Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing

2025-03-31T14:48:31+02:00March 31, 2025|Investor Information, Press Releases, Psychedelic News|

Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapies